Konson Pharmaceuticals and DP Technology Enter Strategic Collaboration to Accelerate AI-Driven Drug Discovery in Nephrology

Jun 06, 2025 12:18 CST Updated 12:18

Consun

Pharmaceutical Manufacturer

DP Technology

Simulation R&D Platform Developer

Consun Pharmaceutical Group and DP Technology Reach Strategic Cooperation to Advance Innovative Target and Drug Discovery in Kidney Disease Field, Jointly Enhancing Drug R&D Efficiency

On June 4, Consun Pharmaceutical Group and DP Technology held an event at DP Technology's Beijing headquarters.AI Pharmaceutical Strategic Cooperation Exchange Meeting and Signing CeremonyAn Meng, Chairman of the Board and President of Consun Pharmaceutical Group, and Wei Jie Sun, Founder and CEO of DP Technology, attended the strategic cooperation signing ceremony and witnessed the signing by both parties. Dr. Ying Du, Vice President of Consun Pharmaceutical Group, General Manager of the R&D Center, and Director of the Nephropathy Drug Research Center, and Qin Li, Partner and Senior Vice President of DP Technology, signed the strategic cooperation agreement on behalf of both parties.

Sun Weijie, founder and CEO of DP Technology, extended a warm welcome to Chairman An and his delegation, and expressed gratitude for the trust and support from Consun Pharmaceutical Group. Sun Weijie stated: "As a publicly listed pharmaceutical company, Consun has profound expertise in the fields of nephrology, imaging, gynecology, and pediatrics. It also demonstrates strong innovation and execution capabilities in new drug development and the application of cutting-edge technologies, which aligns closely with DP Technology's mission to advance...‘AI for Science’The missions are perfectly aligned. We are honored to join hands with Consun Pharmaceutical Group and leverage the strengths of DP Technology inAI for ScienceCore technology advantages in fields such as technical platforms, AI-driven drug research and development, intelligent laboratories, and modernization of traditional Chinese medicine. Both parties believeThrough ecological co-creation, complementary advantages, and collaborative innovation, we can certainly create a model for AI-driven drug research and development and industrial efficiency enhancement, meeting more unmet clinical needs.！”

Consun Pharmaceutical Group Chairman and President An Meng expressed his anticipation for the collaboration with DP Technology in advancing AI pharmaceutical technology. Chairman An stated: "Since its establishment in 1997, Consun Pharmaceutical has always adhered to...‘Inheriting the Past, Innovating for the Future, Good Medicine for the People’The corporate mission is to develop traditional Chinese medicine, adhere to the path of independent innovation, focus on the nephrology field, and expand into imaging, gynecology and pediatrics, orthopedics, dermatology, hepatobiliary, and gastroenterology. It has successfully developed six products with annual sales exceeding 100 million yuan. DP Technology is a global leader in AI-empowered biopharmaceuticals, and its deep insights into AI for Science will greatly support Consun Pharmaceutical Group in achieving intelligent breakthroughs in self-developed innovative drugs. This collaboration is expected to strengthen Consun's leading position in fields such as nephrology.Integrate the industrial advantage resources of pharmaceutical R&D, production, and market sectors to create an intelligent R&D platform, enhance drug development efficiency, and position Consun as an industry leader in the AI-driven drug discovery era.”

Both parties will, in accordance with"Mutual benefit, stable, lasting, efficient, high-quality"The spirit of cooperation, hand in hand,Deep cooperation will be carried out in the fields of innovative target and drug discovery, target mechanism research, process optimization, intelligent laboratories, and modernization of traditional Chinese medicine.

About DP Technology

DP Technology is globalAIFor Science Leaders, AI for Science means using AI to learn a series of scientific principles and knowledge, and further address key issues in scientific research and industrial R&D fields.

Relying on the deep cultivation in the field of interdisciplinary research, DP Technology has built the "Deep Potential·Universe Insight" AI for Science large model system, further addressing key issues in scientific research and industrial development, and bringing research methods across numerous disciplines from the "trial-and-error experimentation / computer" era into the "Pre-trained ModelThe "era" has formed the "innovation-implementation" chain and open ecosystem of AI for Science, built micro-scale industrial infrastructure based on AI for Science, empowered "all walks of life," and created a new generation of R&D systems for the most fundamental biomedical, energy, materials, and information science and engineering research in human economic development.

DP Technology is a national high-tech enterprise, nationalSpecialized, Precise, Unique, and Innovative"Little Giant" enterprises have set up R&D centers in cities such as Beijing, Shanghai, and Shenzhen.The scientific research and technology team is led by an academician of the Chinese Academy of Sciences, bringing together over a hundred outstanding young scientists and engineers from various fields such as mathematics, physics, chemistry, biology, materials, and computer science. Among the company's members, more than 35% hold doctoral or postdoctoral degrees.Core members have won the "Gordon Bell Prize," the highest award in the field of global high-performance computing in 2020. Their related work was selected as one of China's top ten scientific and technological advances in 2020 and one of the ten major technological breakthroughs in the global AI field.